West Pharmaceutical Services, Inc. vs Johnson & Johnson
WST vs JNJ — side-by-side comparison from reported financials. WST leads 3, JNJ leads 8 of 11 comparable metrics.
West Pharmaceutical Services, Inc.
WST · Healthcare
$366.00+0.75%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | WST | JNJ |
|---|---|---|
| Price | $366.00 | $261.79 |
| Market cap | $25.8B | $631B |
| Revenue (TTM) | $3.33B | $97.9B |
| Revenue growth | +2.1% | +5.6% |
| Net margin | 17.0% | 21.5% |
| Free cash flow | $437M | $22.2B |
| Net cash (debt) | $589M | ($27.8B) |
| 1-year price return | +38.9% | +37.0% |
| P/E | 47.7 | 29.9 |
| P/E vs own history (cheap-side %) | 39% | 16% |
| Dividend yield | 0.23% | 2.00% |
| Return on equity | 19% | 26% |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 10,800 | 140,800 |
Full résumé-style profiles: WST CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.